考察[具体植物名称]乙酸乙酯提取物作为COVID-19辅助疗法的疗效和安全性：一项随机、多中心、对照临床试验。（注：原文中“as complementary therapy in COVID-19”前缺少具体植物名称，翻译时添加了[具体植物名称]以保证句子完整通顺）

Examining efficacy and safety of ethyl acetate extract from as complementary therapy in COVID-19: A randomized, multicenter, controlled clinical trial.

作者信息

Amin Mansour, Pouladzadeh Mandana, Yadyad Mohammad Jaafar, Roshanfard Roshanak, Pipelzadeh Mohamad Hasan, Talebi Afshin, Sharif Maakhmalzadeh Behzad, Bijanzadeh Mehdi, Rakipour Nasrin, Alizadehattar Gholamreza, Seyedian Seyed Saeed, Ahmadi Angali Kambiz, Moradi Choghakabodi Parastoo, Akbari Akbar, Maghsodi Fatemeh, Barzegari Ebrahim, Jamalan Maryam, Aalizadeh Reza, Jamalan Mostafa

机构信息

Department of Microbiology, Infection and Tropical Diseases Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Department of Emergency Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

出版信息

Avicenna J Phytomed. 2024 Nov-Dec;14(6):699-710. doi: 10.22038/AJP.2024.24523.

DOI:10.22038/AJP.2024.24523

PMID:40259955

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12009622/

Abstract

OBJECTIVE

Given the apparent life-threatening nature of COVID-19, finding an effective treatment is under investigation.

MATERIALS AND METHODS

We assessed effect of shallomin oral syrup (co IranAmin) as a complementary treatment to improve the clinical outcomes in COVID-19 patients. Patients in the control group received the approved treatment protocol (lopinavir/ritonavir), while those in the intervention group were treated with the oral syrup shallomin in addition to the approved treatment. Clinical status of treated patients was recorded and compared.

RESULTS

There were meaningful differences between the two groups regarding shortened length of hospital stay and the recovery time for cough, myalgia, sore throat, and shortness of breath. No side effect occurred in the intervention group compared to the control group in terms of biochemical and hematological factors.

CONCLUSION

It seems that the treatment with shallomin syrup showed remarkable contribution to the recovery of COVID-19 induced symptoms in the patients under lopinavir/ritonavir therapy.

摘要